TIME Covers Groundbreaking Thalassemia Clinical Trial

September 18, 2018 – TIME has published an article on UCSF’s groundbreaking clinical trial involving in utero stem cell transplantations on fetuses affected with alpha-thalassemia major (ATM). Read TIME’s article at the following link: http://time.com/5394912/stem-cell-treatment/.

Last year, CAF interviewed the principal investigator of this clinical trial, Dr. Tippi MacKenzie. Read that interview here: https://www.thalassemia.org/caf-interviews-dr-tippi-mackenzie/.

Secured By miniOrange